Labiotech.eu4d
The biggest biotech funding rounds in March 2025
The companies Isomorphic Labs, DBV Technologies, and Genfit bagged the biggest biotech funding rounds overall in March 2025.
GitHub6d
README.md
1.The software "compute [t,p]-spe and D-spe.exe" produces: [t,p]-spectra of all vertices for -maxdegree <= t <= 0, p=-1,-2 ... of graphs in the series, and then enter the shared (partial) name xxx, ...
Na Presseportal5d
Isomorphic Labs
Isomorphic Labs announces $600 million funding to further develop its next-generation AI drug design engine and advance therapeutic programs into the clinic London (ots/PRNewswire) - Isomorphic ...
Alphabet’s Isomorphic Labs raises $600M in first funding round for AI drug business
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
eWeek3d
‘Solving All Disease’ Using AI is the Mission of Alphabet’s Isomorphic Labs – Its $600M in Funding Will Help
Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...
BioPharma Dive5d
Isomorphic raises $600M on big ambitions for AI drugmaking tech
The drug discovery company, which has partnerships with Eli Lilly and Novartis, is developing AI models to design drugs and ...
SiliconANGLE5d
Alphabet spinout Isomorphic Labs raises $600M for its AI drug design engine
One of them is Google LLC’s AlphaFold 3 model. It’s an improved version of AlphaFold 2, the AI system for which Isomorphic Labs CEO Demis Hassabis won half of last year’s Nobel Prize in ...
TechCrunch5d
Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised external capital for the first time. The $600 million round was led by Thrive Capital ...
FierceBiotech6d
Alphabet's AI biotech Isomorphic Labs hauls in $600M to power next-gen drug design model
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding within Google parent company Alphabet, raising $600 million to advance its ...
The New York Times6d
Isomorphic Labs, Google’s A.I. Drug Business, Raises $600 Million
Now Isomorphic Labs, the division within the software giant meant to develop and commercialize the technology, is taking another big step: raising money from an outside investor. Isomorphic ...
Demis Hassabis on Isomorphic’s $600 million raise, AI, and healthcare’s future
Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, Isomorphic Labs.